1.Clinical Practice Guidelines for Managing Frailty in Community-Dwelling Korean Elderly Adults in Primary Care Settings
Hyo-Sun YOU ; Yu-Jin KWON ; Sunyoung KIM ; Yang-Hyun KIM ; Ye-seul KIM ; Yonghwan KIM ; Yong-kyun ROH ; Byoungjin PARK ; Young Kyu PARK ; Chang-Hae PARK ; Joung Sik SON ; Jinyoung SHIN ; Hyun-Young SHIN ; Bumjo OH ; Jae-woo LEE ; Jae Yong SHIM ; Chang Won WON ; Ji Won YOO ; Sang-Hyun LEE ; Hee-Taik KANG ; Duk Chul LEE
Korean Journal of Family Medicine 2021;42(6):413-424
Aging has become a global problem, and the interest in healthy aging is growing. Healthy aging involves a focus on the maintenance of the function and well-being of elderly adults, rather than a specific disease. Thus, the management of frailty, which is an accumulated decline in function, is important for healthy aging. The adaptation method was used to develop clinical practice guidelines on frailty management that are applicable in primary care settings. The guidelines were developed in three phases: preparation (organization of committees and establishment of the scope of development), literature screening and evaluation (selection of the clinical practice guidelines to be adapted and evaluation of the guidelines using the Korean Appraisal of Guidelines for Research and Evaluation II tool), and confirmation of recommendations (three rounds of Delphi consensus and internal and external reviews). A total of 16 recommendations (five recommendations for diagnosis and assessment, 11 recommendations for intervention of frailty) were made through the guideline development process. These clinical practice guidelines provide overall guidance on the identification, evaluation, intervention, and monitoring of frailty, making them applicable in primary care settings. As aging and “healthy aging” become more and more important, these guidelines are also expected to increase in clinical usefulness.
2.Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
Se Hoon LEE ; Boram LEE ; Joon Ho SHIM ; Kwang Woo LEE ; Jae Won YUN ; Sook Young KIM ; Tae You KIM ; Yeul Hong KIM ; Young Hyeh KO ; Hyun Cheol CHUNG ; Chang Sik YU ; Jeeyun LEE ; Sun Young RHA ; Tae Won KIM ; Kyung Hae JUNG ; Seock Ah IM ; Hyeong Gon MOON ; Sukki CHO ; Jin Hyoung KANG ; Jihun KIM ; Sang Kyum KIM ; Han Suk RYU ; Sang Yun HA ; Jong Il KIM ; Yeun Jun CHUNG ; Cheolmin KIM ; Hyung Lae KIM ; Woong Yang PARK ; Dong Young NOH ; Keunchil PARK
Cancer Research and Treatment 2019;51(1):211-222
PURPOSE: With the emergence of next-generation sequencing (NGS) technology, profiling a wide range of genomic alterations has become a possibility resulting in improved implementation of targeted cancer therapy. In Asian populations, the prevalence and spectrum of clinically actionable genetic alterations has not yet been determined because of a lack of studies examining high-throughput cancer genomic data. MATERIALS AND METHODS: To address this issue, 1,071 tumor samples were collected from five major cancer institutes in Korea and analyzed using targeted NGS at a centralized laboratory. Samples were either fresh frozen or formalin-fixed, paraffin embedded (FFPE) and the quality and yield of extracted genomic DNA was assessed. In order to estimate the effect of sample condition on the quality of sequencing results, tissue preparation method, specimen type (resected or biopsied) and tissue storage time were compared. RESULTS: We detected 7,360 non-synonymous point mutations, 1,164 small insertions and deletions, 3,173 copy number alterations, and 462 structural variants. Fifty-four percent of tumors had one or more clinically relevant genetic mutation. The distribution of actionable variants was variable among different genes. Fresh frozen tissues, surgically resected specimens, and recently obtained specimens generated superior sequencing results over FFPE tissues, biopsied specimens, and tissues with long storage duration. CONCLUSION: In order to overcome, challenges involved in bringing NGS testing into routine clinical use, a centralized laboratory model was designed that could improve the NGS workflows, provide appropriate turnaround times and control costs with goal of enabling precision medicine.
Academies and Institutes
;
Asian Continental Ancestry Group
;
DNA
;
Humans
;
Korea
;
Methods
;
Paraffin
;
Point Mutation
;
Precision Medicine
;
Prevalence
3.High Prevalence of Asthma in Elderly Women: Findings From a Korean National Health Database and Adult Asthma Cohort.
So Young PARK ; Jung Hyun KIM ; Hyo Jung KIM ; Bomi SEO ; Oh Young KWON ; Hun Soo CHANG ; Hyouk Soo KWON ; Tae Bum KIM ; Ho KIM ; Choon Sik PARK ; Hee Bom MOON ; You Sook CHO
Allergy, Asthma & Immunology Research 2018;10(4):387-396
PURPOSE: The prevalence and burden of asthma is increasing worldwide. In this study, we analyzed 3 different Korean national health survey datasets to determine the general features of adult asthma in Korea and to obtain basic information that would support future strategies for better management of adult asthma. METHODS: The surveys used in this study included the Korea National Health and Nutrition Examination Survey (KNHANES), Korea Community Health Survey (KCHS) and National Health Insurance Service-National Sample Cohort (NHIS-NSC). We investigated annual asthma prevalence, evaluating the rate and risk factors of asthma exacerbation by age and sex, and clinical data of 1,832 patients with asthma who were registered in the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) were analyzed to elucidate risk factors for asthma exacerbation. We also analyzed another asthma cohort and added it as replication data. RESULTS: In the KNHANES database, annual asthma prevalence rates varied from 1.2% to 3.1%. In the KCHS database, overall prevalence increased, with significant regional differences (1.6%–2.1%). The NHIS-NSC indicated a gradual increase in annual asthma prevalence from 4.5% to 6.2%. Interestingly, all 3 surveys indicated the highest prevalence of asthma among elderly women. In addition, elderly women with asthma had a significantly higher risk of asthma exacerbation (odds ratio [OR], 1.87; 95% confidence interval [CI], 1.19–2.93; P=0.006). Approximately 11% of patients were classified as having severe asthma. An asthma cohort analysis identified female sex, low baseline pulmonary function, longer treatment duration, high variability in pulmonary function and significant changes in Asthma Control Test scores as risk factors for asthma exacerbation. CONCLUSIONS: The prevalence of asthma in Korea is consistently high among elderly and female populations. These results should lay the foundation for strategies for effective asthma prevention and management; elderly female patients with asthma should receive particular attention.
Adult*
;
Aged*
;
Asthma*
;
Cohort Studies*
;
Dataset
;
Female
;
Health Surveys
;
Humans
;
Incidence
;
Korea
;
National Health Programs
;
Nutrition Surveys
;
Prevalence*
;
Risk Factors
4.Clinical Characteristics of Exacerbation-Prone Adult Asthmatics Identified by Cluster Analysis.
Mi Ae KIM ; Seung Woo SHIN ; Jong Sook PARK ; Soo Taek UH ; Hun Soo CHANG ; Da Jeong BAE ; You Sook CHO ; Hae Sim PARK ; Ho Joo YOON ; Byoung Whui CHOI ; Yong Hoon KIM ; Choon Sik PARK
Allergy, Asthma & Immunology Research 2017;9(6):483-490
PURPOSE: Asthma is a heterogeneous disease characterized by various types of airway inflammation and obstruction. Therefore, it is classified into several subphenotypes, such as early-onset atopic, obese non-eosinophilic, benign, and eosinophilic asthma, using cluster analysis. A number of asthmatics frequently experience exacerbation over a long-term follow-up period, but the exacerbation-prone subphenotype has rarely been evaluated by cluster analysis. This prompted us to identify clusters reflecting asthma exacerbation. METHODS: A uniform cluster analysis method was applied to 259 adult asthmatics who were regularly followed-up for over 1 year using 12 variables, selected on the basis of their contribution to asthma phenotypes. After clustering, clinical profiles and exacerbation rates during follow-up were compared among the clusters. RESULTS: Four subphenotypes were identified: cluster 1 was comprised of patients with early-onset atopic asthma with preserved lung function, cluster 2 late-onset non-atopic asthma with impaired lung function, cluster 3 early-onset atopic asthma with severely impaired lung function, and cluster 4 late-onset non-atopic asthma with well-preserved lung function. The patients in clusters 2 and 3 were identified as exacerbation-prone asthmatics, showing a higher risk of asthma exacerbation. CONCLUSIONS: Two different phenotypes of exacerbation-prone asthma were identified among Korean asthmatics using cluster analysis; both were characterized by impaired lung function, but the age at asthma onset and atopic status were different between the two.
Adult*
;
Asthma
;
Clothing
;
Cluster Analysis*
;
Eosinophils
;
Follow-Up Studies
;
Humans
;
Inflammation
;
Lung
;
Methods
;
Phenotype
5.Second Korean guidelines for the management of ulcerative colitis.
Chang Hwan CHOI ; Won MOON ; You Sun KIM ; Eun Soo KIM ; Bo In LEE ; Yunho JUNG ; Yong Sik YOON ; Heeyoung LEE ; Dong Il PARK ; Dong Soo HAN
Intestinal Research 2017;15(1):7-37
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during exacerbation of the disease. The incidence and prevalence of UC in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Various medical and surgical therapies, including biologics, are currently used for the management of UC. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Therefore, the IBD study group of the Korean Association for the Study of Intestinal Diseases established the first Korean guidelines for the management of UC in 2012. This is an update of the first guidelines. It was generally made by the adaptation of several foreign guidelines as was the first edition, and encompasses treatment of active colitis, maintenance of remission, and indication of surgery for UC. The specific recommendations are presented with the quality of evidence and classification of recommendations.
Biological Products
;
Classification
;
Colitis
;
Colitis, Ulcerative*
;
Disease Management
;
Humans
;
Incidence
;
Inflammatory Bowel Diseases
;
Intestinal Diseases
;
Korea
;
Prevalence
;
Quality of Life
;
Ulcer*
6.Second Korean Guideline for the Management of Ulcerative Colitis.
Chang Hwan CHOI ; Won MOON ; You Sun KIM ; Eun Soo KIM ; Bo In LEE ; Yunho JUNG ; Yong Sik YOON ; Heeyoung LEE ; Dong Il PARK ; Dong Soo HAN
The Korean Journal of Gastroenterology 2017;69(1):1-28
Ulcerative colitis (UC) is a chronic inflammatory bowel disorder characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during exacerbation of the disease. The incidence and prevalence of UC in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Various medical and surgical therapies, including biologics, are currently used for the management of UC. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Therefore, the Inflammatory Bowel Disease Study Group of the Korean Association for the Study of Intestinal Diseases established the first Korean guideline for the management of UC in 2012. This is an update of the first guideline. It was generally made by the adaptation of several foreign guidelines as was the first edition, and encompasses treatment of active colitis, maintenance of remission, and indication of surgery for UC. The specific recommendations are presented with the quality of evidence and classification of recommendations.
Biological Products
;
Classification
;
Colitis
;
Colitis, Ulcerative*
;
Humans
;
Incidence
;
Inflammatory Bowel Diseases
;
Intestinal Diseases
;
Korea
;
Prevalence
;
Quality of Life
;
Ulcer*
7.Sparganosis of the Unilateral Breast: A Case Report.
Hyung Suk KIM ; Man Sik SHIN ; Chang Jong KIM ; Sun Hyung YOU ; Yong Hwa EOM ; Tae Kyung YOO ; Ahwon LEE ; Byung Joo SONG ; Byung Joo CHAE
The Korean Journal of Parasitology 2017;55(4):421-424
Sparganosis is a parasitic infection caused by the sparganum, the plercercoid of the genus Spirometra. The preoperative diagnosis of breast sparganosis is difficult in most cases because it is a rare parasitic infection less than 2% of all cases. We report a 62-year-old woman case of breast sparganosis that were confirmed by surgical removal of worms from the right breast. The radiologic images of the patient also revealed characteristic features of breast sparganosis. The patient described the migrating palpable breast mass, which strongly suggested the possibility of breast sparganosis. The treatment of choice and confirmative diagnosis for sparganosis are complete surgical extraction of the sparganum irrespective of infected site. Inspection of the mass site with detailed medical history and radiological examinations are important for preoperative diagnosis of sparganosis patients.
Breast*
;
Diagnosis
;
Female
;
Humans
;
Mammography
;
Middle Aged
;
Sparganosis*
;
Sparganum
;
Spirometra
;
Ultrasonography
8.Diffuse Infiltrative Splenic Lymphoma: Diagnostic Efficacy of Arterial-Phase CT.
Jeong Eun LEE ; June Sik CHO ; Kyung Sook SHIN ; Song Soo KIM ; Sun Kyoung YOU ; Jae Woo PARK ; Hye Soo SHIN ; Yeo Chang YOON
Korean Journal of Radiology 2016;17(5):734-741
OBJECTIVE: To evaluate the diagnostic performance of obliteration of normal heterogeneous enhancement of the spleen (ONHES) on arterial phase (AP) computed tomography (CT) images in diffuse infiltrative splenic lymphoma (DISL). MATERIALS AND METHODS: One hundred and thirty-six patients with lymphoma who had undergone two-phase (arterial and portal venous) abdominal CT were included in this study. We retrospectively evaluated the diagnostic performance of ONHES on AP CT in diagnosing DISL. Two observers evaluated ONHES on AP CT using the 5-point confidence level and assessed the presence or absence of subjective splenomegaly on axial CT images. Another two observers measured the splenic index as proposed by objective CT criteria. Statistical analysis included interobserver agreement and diagnostic performance of CT findings. RESULTS: Eleven of the 136 patients with lymphoma had DISL. The area under the receiver operating characteristic curve of ONHES (0.948 for observer 1 and 0.922 for observer 2) was superior to that of the splenic index (0.872 for observer 3 and 0.877 for observer 4), but the difference was not statistically significant (p > 0.05). The diagnostic performance of ONHES in conjunction with subjective splenomegaly showed higher diagnostic performance, as compared with subjective splenomegaly alone (accuracy: 100% and 85.3% for observer 1, 98.5% and 87.5% for observer 2; positive predictive value: 100% and 35.5% for observer 1, 90.9% and 39.3% for observer 2, respectively). CONCLUSION: Obliteration of normal heterogeneous enhancement of the spleen in conjunction with subjective splenomegaly can improve the diagnostic performance for DISL. Our results suggest that ONHES on AP CT images could be useful as an adjunctive diagnostic indicator of DISL in patients with lymphoma.
Humans
;
Lymphoma*
;
Retrospective Studies
;
ROC Curve
;
Spleen
;
Splenomegaly
;
Tomography, X-Ray Computed
9.Impact of Atopy on Asthma and Allergic Rhinitis in the Cohort for Reality and Evolution of Adult Asthma in Korea.
An Soo JANG ; Sang Heon KIM ; Tae Bum KIM ; Heung Woo PARK ; Sae Hoon KIM ; Yoon Seok CHANG ; Jae Hyun LEE ; You Sook CHO ; Jung Won PARK ; Dong Ho NAHM ; Young Joo CHO ; Sang Heon CHO ; Ho Joo YOON ; Byoung Whui CHOI ; Hee Bom MOON ; Choon Sik PARK
Allergy, Asthma & Immunology Research 2013;5(3):143-149
PURPOSE: Atopy is an important cause of asthma. Few data on the prevalence of atopy or comparisons with clinical characteristics of asthma in Korean patients have been published. We evaluated the effects of atopy on clinical profiles and airway inflammation in Korean asthmatics. METHODS: We retrospectively enrolled 1,492 asthmatics from the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) cohort who had undergone skin prick tests for aeroallergens. The patients' clinical characteristics, lung function, PC20, and sputum and blood inflammatory cell counts were compared based on the presence or absence of atopy. Atopy was defined as one or more positive reactions (A/H ratio >1) on a skin prick test. RESULTS: Among 11 aeroallergens, house dust mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) were the most prevalent cause of a positive skin prick test. As compared with non-atopic asthmatics, atopic asthmatics showed early onset of the disease. Atopic patients with asthma had a higher FEV1, FVC, and FEV1/FVC as compared with non-atopic patients with asthma. In addition, asthmatics without atopy had more uncontrolled asthma (P=0.001) and severe rhinitis (P<0.05) as compared with atopic asthmatics. Smoking, as measured in pack years, was higher in the non-atopic asthmatics than in the atopic asthmatics. The erythrocyte sedimentation rate was higher in non-atopic asthmatics than in the atopic asthmatics and patients with non-atopic asthma had a higher sputum neutrophil count than did those with atopic asthma. CONCLUSIONS: Our data indicate that atopic asthmatics had an early onset of disease and high IgE levels, while the non-atopic asthmatics had decreased lung function and a high sputum neutrophil count, suggesting that a different approach is needed to treat atopic asthma.
Adult
;
Allergens
;
Asthma
;
Blood Sedimentation
;
Cell Count
;
Cohort Studies
;
Humans
;
Immunoglobulin E
;
Inflammation
;
Korea
;
Lung
;
Neutrophils
;
Prevalence
;
Pyroglyphidae
;
Retrospective Studies
;
Rhinitis
;
Rhinitis, Allergic, Perennial
;
Skin
;
Smoke
;
Smoking
;
Sputum
10.Safety and Efficacy of Modern Insulin Analogues.
Hye Jin YOO ; Keun Yong PARK ; Kang Seo PARK ; Kyu Jeung AHN ; Kyung Wan MIN ; Jeong Hyun PARK ; Sang Ah CHANG ; Bong Soo CHA ; Dong Jun KIM ; Yong Seong KIM ; Tae Keun OH ; Suk CHON ; Il Seong NAM-GOONG ; Mi Jin KIM ; Hye Soon KIM ; Young Sik CHOI ; You Hern AHN ; Sora LEE ; Sei Hyun BAIK
Diabetes & Metabolism Journal 2013;37(3):181-189
BACKGROUND: A1chieve(R) was a noninterventional study evaluating the clinical safety and efficacy of biphasic insulin aspart 30, insulin detemir, and insulin aspart. METHODS: Korean type 2 diabetes patients who have not been treated with the study insulin or have started it within 4 weeks before enrollment were eligible for the study. The patient selection and the choice of regimen were at the discretion of the physician. The safety and efficacy information was collected from the subjects at baseline, week 12, and week 24. The number of serious adverse drug reactions (SADRs) was the primary endpoint. The changes of clinical diabetic markers at week 12 and/or at week 24 compared to baseline were the secondary endpoints. RESULTS: Out of 4,058 exposed patients, 3,003 completed the study. During the study period, three SADRs were reported in three patients (0.1%). No major hypoglycemic episodes were observed and the rate of minor hypoglycemic episodes marginally decreased during 24 weeks (from 2.77 to 2.42 events per patient-year). The overall quality of life score improved (from 66.7+/-15.9 to 72.5+/-13.5) while the mean body weight was slightly increased (0.6+/-3.0 kg). The 24-week reductions in glycated hemoglobin, fasting plasma glucose and postprandial plasma glucose were 1.6%+/-2.2%, 2.5+/-4.7 mmol/L, and 4.0+/-6.4 mmol/L, respectively. CONCLUSION: The studied regimens showed improvements in glycemic control with low incidence of SADRs, including no incidence of major hypoglycemic episodes in Korean patients with type 2 diabetes.
Biphasic Insulins
;
Body Weight
;
Diabetes Mellitus, Type 2
;
Drug Toxicity
;
Fasting
;
Glucose
;
Hemoglobins
;
Humans
;
Incidence
;
Insulin
;
Insulin Aspart
;
Insulin, Isophane
;
Insulin, Long-Acting
;
Patient Selection
;
Plasma
;
Quality of Life
;
Republic of Korea
;
Treatment Outcome
;
Insulin Detemir

Result Analysis
Print
Save
E-mail